Literature DB >> 2402727

Effect of forced expirations on mucus clearance in patients with chronic airflow obstruction: effect of lung recoil pressure.

C P van der Schans1, D A Piers, H Beekhuis, G H Koëter, T W van der Mark, D S Postma.   

Abstract

Spontaneous mucus clearance and the effect of forced expirations and coughing on mucus clearance were investigated in eight patients with chronic airflow obstruction and low elastic recoil pressure (emphysema group: mean FEV1 45% predicted) and in seven patients with chronic airflow obstruction and normal elastic recoil pressure (chronic bronchitis group: mean FEV1 57% predicted). Mucus clearance was measured in a central and a peripheral lung region by a radioactive aerosol tracer technique. Spontaneous mucus clearance from the peripheral lung region was higher in the patients with emphysema than in those with chronic bronchitis. There was no difference in central mucus clearance between the two groups. Mucus clearance from the peripheral lung region increased significantly during forced expirations and coughing in the patients with chronic bronchitis but not in those with emphysema. It is concluded that in patients with chronic airflow obstruction and regular sputum production spontaneous peripheral mucus clearance is greater in those with decreased elastic recoil pressure. Physiotherapy that includes forced expirations and coughing can enhance mucus clearance in such patients when elastic recoil pressure is normal but is unlikely to be effective when elastic recoil pressure is decreased.

Entities:  

Mesh:

Year:  1990        PMID: 2402727      PMCID: PMC462646          DOI: 10.1136/thx.45.8.623

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

1.  Wave-speed limitation on expiratory flow-a unifying concept.

Authors:  S V Dawson; E A Elliott
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-09

2.  Tracheobronchial clearance in patients with emphysema associated with alpha1-antitrypsin deficiency.

Authors:  B Mossberg; K Philipson; P Camner
Journal:  Scand J Respir Dis       Date:  1978-02

3.  Cough.

Authors:  D E Leith
Journal:  Phys Ther       Date:  1968-05

4.  Resistance to two-phase gas-liquid flow in airways.

Authors:  S W Clarke; J G Jones; D R Oliver
Journal:  J Appl Physiol       Date:  1970-10       Impact factor: 3.531

5.  An evaluation of the forced expiration technique as an adjunct to postural drainage.

Authors:  J A Pryor; B A Webber
Journal:  Physiotherapy       Date:  1979-10       Impact factor: 3.358

6.  Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy.

Authors:  P P Sutton; R A Parker; B A Webber; S P Newman; N Garland; M T Lopez-Vidriero; D Pavia; S W Clarke
Journal:  Eur J Respir Dis       Date:  1983-01

7.  The dynamics of cough in health and in chronic bronchitis.

Authors:  J Langlands
Journal:  Thorax       Date:  1967-01       Impact factor: 9.139

8.  Significance of the relationship between lung recoil and maximum expiratory flow.

Authors:  J Mead; J M Turner; P T Macklem; J B Little
Journal:  J Appl Physiol       Date:  1967-01       Impact factor: 3.531

9.  Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis.

Authors:  J A Pryor; B A Webber; M E Hodson; J C Batten
Journal:  Br Med J       Date:  1979-08-18

10.  Human ciliary beat frequency in epithelium from intrathoracic and extrathoracic airways.

Authors:  J Rutland; W M Griffin; P J Cole
Journal:  Am Rev Respir Dis       Date:  1982-01
View more
  2 in total

Review 1.  Home treatment of COPD exacerbations.

Authors:  D S Postma; N H Ten Hacken; H A Kerstjens; G H Koëter
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Effect of positive expiratory pressure breathing in patients with cystic fibrosis.

Authors:  C P van der Schans; T W van der Mark; G de Vries; D A Piers; H Beekhuis; J E Dankert-Roelse; D S Postma; G H Koëter
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.